精品:2017 ADA 糖尿病医学诊疗标准(英文、中文版及解读)

2017-05-05 MedSci MedSci原创

2016年12月,美国糖尿病学会(ADA)发布了2017版糖尿病医学诊疗标准。ADA制定的《糖尿病医学诊疗标准》是指导糖尿病医生临床实践的重要指南之一,每年都会对该指南进行更新和修改。梅斯小编整理该指南的中文翻译版和解读,供大家参考。 一、2017 ADA 糖尿病医学诊疗标准(英文版) 2017版糖尿病诊疗标准主要内容包括:一、改进治疗的策略;二、糖尿病的分型和诊断;三、综合医学评

2016年12月,美国糖尿病学会(ADA)发布了2017版糖尿病医学诊疗标准。ADA制定的《糖尿病医学诊疗标准》是指导糖尿病医生临床实践的重要指南之一,每年都会对该指南进行更新和修改。梅斯小编整理该指南的中文翻译版和解读,供大家参考。

一、2017 ADA 糖尿病医学诊疗标准(英文版)
2017版糖尿病诊疗标准主要内容包括:一、改进治疗的策略;二、糖尿病的分型和诊断;三、综合医学评估和评估合并症;四、生活方式管理;五、预防或延缓2型糖尿病;六、血糖目标;七、2型糖尿病治疗的肥胖管理;八、血糖控制的药物治疗;九、心血管疾病和危险因素管理;十、微血管并发症和足病;十一、 老年人糖尿病的管理;十二、儿童和青少年糖尿病的管理;十三、 孕期糖尿病管理;十四、院内糖尿病管理。 二、2017年ADA糖尿病诊疗标准(中文版)
美国糖尿病协会(ADA)近日更新《2015年ADA糖尿病医学诊疗标准》(Standardsof Medical Care in Diabetes—2015),全文共14个章节。以下是2015年ADA糖尿病新指南第1~13章节推荐要点(Recommendedations)翻译和推荐证据级别。(第14章节无推荐要点)。基于最新研究证据,新版ADA指南对多项诊断与治疗建议进行了更新,以下是指南内容翻译。海南医学院第一附属医院 王新军 王转锁
三、2017 年ADA 糖尿病医学诊疗标准解读
美国糖尿病学会(American Diabetes Association,ADA)自1998 年起开始发布糖尿病医学诊疗标准,并从2002 年起,依据最新的研究证据,每年对标准进行更新,是指导临床医师进行糖尿病治疗临床实践的重要指南之一。近日,ADA 在Diabetes Care 上以增刊形式发表了最新的糖尿病医学诊疗标准,旨在为临床医师、研究人员以及患者等提供糖尿病管理要素、治疗目标和治疗质量的评估工具。本文就其中热点问题及重要更新内容进行解读。上海交通大学附属第六人民医院 应令雯,周健

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1954754, encodeId=0dda1954e5461, content=<a href='/topic/show?id=391b91e0533' target=_blank style='color:#2F92EE;'>#诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91705, encryptionId=391b91e0533, topicName=诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Aug 06 11:52:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=195178, encodeId=e7211951e8de, content=学习了,诊断标准大部分没改变, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon May 08 05:52:54 CST 2017, time=2017-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264619, encodeId=8d601264619ba, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun May 07 06:52:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194688, encodeId=827819468820, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sat May 06 19:14:45 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194307, encodeId=cb2319430e66, content=糖尿病诊疗标准的新进展!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=d41c2055892, createdName=184****9840, createdTime=Sat May 06 00:18:20 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194217, encodeId=807c19421e04, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri May 05 15:58:06 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1954754, encodeId=0dda1954e5461, content=<a href='/topic/show?id=391b91e0533' target=_blank style='color:#2F92EE;'>#诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91705, encryptionId=391b91e0533, topicName=诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Aug 06 11:52:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=195178, encodeId=e7211951e8de, content=学习了,诊断标准大部分没改变, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon May 08 05:52:54 CST 2017, time=2017-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264619, encodeId=8d601264619ba, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun May 07 06:52:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194688, encodeId=827819468820, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sat May 06 19:14:45 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194307, encodeId=cb2319430e66, content=糖尿病诊疗标准的新进展!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=d41c2055892, createdName=184****9840, createdTime=Sat May 06 00:18:20 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194217, encodeId=807c19421e04, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri May 05 15:58:06 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
    2017-05-08 有备才能无患

    学习了,诊断标准大部分没改变

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1954754, encodeId=0dda1954e5461, content=<a href='/topic/show?id=391b91e0533' target=_blank style='color:#2F92EE;'>#诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91705, encryptionId=391b91e0533, topicName=诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Aug 06 11:52:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=195178, encodeId=e7211951e8de, content=学习了,诊断标准大部分没改变, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon May 08 05:52:54 CST 2017, time=2017-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264619, encodeId=8d601264619ba, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun May 07 06:52:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194688, encodeId=827819468820, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sat May 06 19:14:45 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194307, encodeId=cb2319430e66, content=糖尿病诊疗标准的新进展!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=d41c2055892, createdName=184****9840, createdTime=Sat May 06 00:18:20 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194217, encodeId=807c19421e04, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri May 05 15:58:06 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
    2017-05-07 docwu2019
  4. [GetPortalCommentsPageByObjectIdResponse(id=1954754, encodeId=0dda1954e5461, content=<a href='/topic/show?id=391b91e0533' target=_blank style='color:#2F92EE;'>#诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91705, encryptionId=391b91e0533, topicName=诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Aug 06 11:52:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=195178, encodeId=e7211951e8de, content=学习了,诊断标准大部分没改变, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon May 08 05:52:54 CST 2017, time=2017-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264619, encodeId=8d601264619ba, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun May 07 06:52:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194688, encodeId=827819468820, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sat May 06 19:14:45 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194307, encodeId=cb2319430e66, content=糖尿病诊疗标准的新进展!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=d41c2055892, createdName=184****9840, createdTime=Sat May 06 00:18:20 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194217, encodeId=807c19421e04, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri May 05 15:58:06 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
    2017-05-06 Chongyang Zhang

    签到学习了很多

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1954754, encodeId=0dda1954e5461, content=<a href='/topic/show?id=391b91e0533' target=_blank style='color:#2F92EE;'>#诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91705, encryptionId=391b91e0533, topicName=诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Aug 06 11:52:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=195178, encodeId=e7211951e8de, content=学习了,诊断标准大部分没改变, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon May 08 05:52:54 CST 2017, time=2017-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264619, encodeId=8d601264619ba, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun May 07 06:52:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194688, encodeId=827819468820, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sat May 06 19:14:45 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194307, encodeId=cb2319430e66, content=糖尿病诊疗标准的新进展!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=d41c2055892, createdName=184****9840, createdTime=Sat May 06 00:18:20 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194217, encodeId=807c19421e04, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri May 05 15:58:06 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
    2017-05-06 184****9840

    糖尿病诊疗标准的新进展!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1954754, encodeId=0dda1954e5461, content=<a href='/topic/show?id=391b91e0533' target=_blank style='color:#2F92EE;'>#诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91705, encryptionId=391b91e0533, topicName=诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Aug 06 11:52:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=195178, encodeId=e7211951e8de, content=学习了,诊断标准大部分没改变, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon May 08 05:52:54 CST 2017, time=2017-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264619, encodeId=8d601264619ba, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun May 07 06:52:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194688, encodeId=827819468820, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sat May 06 19:14:45 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194307, encodeId=cb2319430e66, content=糖尿病诊疗标准的新进展!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=d41c2055892, createdName=184****9840, createdTime=Sat May 06 00:18:20 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194217, encodeId=807c19421e04, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri May 05 15:58:06 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
    2017-05-05 三生有幸9135

    学习一下谢谢分享

    0

相关资讯

BMC Medicine:“1.5型糖尿病”的发现将全面刷新糖尿病的诊断与治疗!

研究人员研究了与两种更为人熟悉的糖尿病类型(1型和2型)具有相同特征的一种新的成人糖尿病发病形式,发现了可能提供更准确诊断和治疗线索的基因学影响。

没有想不到:糖尿病治疗及检测刮起“智能风”

知道吗?糖尿病治疗及检测也刮起了“智能风”。

Sci Rep:糖尿病和神经胶质瘤之间存在逆关联!

神经胶质瘤是一种异质性原发性脑肿瘤,目前没有可以长期存活的治疗方法。诊断为胶质母细胞瘤的患者平均生存期14个月。症状通常仅在诊断前三个月才发生;因此,重要的是在症状发作前确定临床前肿瘤的指标。

Diabetes Care:糖尿病可增加慢性心力衰竭患者致死率!

目前已知,糖尿病可能增加患心血管疾病(CVD)风险,同时也增加了致死风险。由于糖尿病患病率在世界范围内上升,且慢性心力衰竭(CHF)在人口老龄化中日益普遍,因此,应及时研究糖尿病1年内不良反应对CHF患者的影响。

专题:精华指南在手,糖尿病防控不再难

糖尿病是一组以高血糖为特征的代谢性疾病。糖尿病常见并发症包 括卒中、心肌梗死、视网膜病变、糖尿病足、糖尿病肾病肾脏衰竭等。在欧美国家,糖尿病视网膜病变和糖尿病肾病分别是首位致盲和致终末期肾病的原因,尽早科学开展综合治疗、规范管理、并发症的监测和及早干预,有利于减少、延缓和控制糖尿病的并发症,使得大多数糖尿病患者可以享受正常生活。梅斯小编整理糖尿病相关指南,供大家参考! 一、预 防 1、

Sci Rep:血糖和神经胶质瘤之间意想不到的联系

神经胶质瘤是一种异质性原发性脑肿瘤,目前没有可以长期存活的治疗方法。诊断为胶质母细胞瘤的患者平均生存期14个月。症状通常仅在诊断前三个月才发生;因此,重要的是在症状发作前确定临床前肿瘤的指标。